Fresenius | FRE - Ordinary Share Capital


Fresenius reported EUR563.24M in Ordinary Share Capital for its fiscal quarter ending in September of 2026.





Ordinary Share Capital Change Date
Akzo Nobel EUR 171.41M 0 Sep/2026
Alcon AG USD 487.4M 0 Jun/2026
AstraZeneca USD 1.55B 28K Sep/2026
BASF EUR 884.32M 0 Sep/2026
Bayer EUR 982.42M 0 Sep/2026
Beiersdorf EUR 217.02M 1.9M Jun/2026
DaVita Healthcare Partners USD 63.96M 2.23M Jun/2026
Demant DKK 208.86M 2.04M Jun/2026
E.ON EUR 2.61B 0 Jun/2026
Essilor EUR 463.19M 144.06K Jun/2026
Fresenius EUR 563.24M 0 Sep/2026
Fresenius Medical Care EUR 259.51M 6.6M Sep/2026
Getinge SEK 272.37M 136.37M Jun/2026
Givaudan CHF 9.23M 0 Dec/2025
GlaxoSmithKline GBP 2.02B 2.05B Sep/2026
GN Store Nord DKK 145.61M 0 Sep/2026
GRIFOLS EUR 680.58M 0 Sep/2026
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Lonza CHF 68.64M 0 Dec/2025
Merck EUR 434.78M 0 Jun/2026
Novartis USD 1.89B 12.09M Sep/2026
Philips EUR 977.61M 186K Sep/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
RWE EUR 779.98M 66.42M Jun/2026
Sanofi EUR 1.2B 0 Sep/2026
Smith & Nephew USD 875.95M 11.64K Jun/2026